[an error occurred while processing this directive] | ����Ƥ���Բ�ѧ��־ 2006, 32(5) 300-302 DOI: ISSN: 2096-5540 CN: 32-1880/R | ||||||||||||||||||||||||||||||||||||||||||||||
����Ŀ¼ | ����Ŀ¼ | ������� | ������ [��ӡ��ҳ] [�ر�] | |||||||||||||||||||||||||||||||||||||||||||||||
���� |
| ||||||||||||||||||||||||||||||||||||||||||||||
TCR����������Ƥ��Tϸ���ܰ����е�Ӧ�� | |||||||||||||||||||||||||||||||||||||||||||||||
��һƽ, ¬��÷ | |||||||||||||||||||||||||||||||||||||||||||||||
ɽ��ʡƤ�����Բ������о���, ����250022 | |||||||||||||||||||||||||||||||||||||||||||||||
ժҪ��
Tϸ���ڳ��������ͨ��Tϸ�����������������,�Ӷ�����������ʶ��ԭ������,����һ�����е��κ�ʧ�����ᵼ�¼�����Ƥ��Tϸ���ܰ��������ڵ����ܰ�ϸ���Ķ�����ֳ�����µ�,������֯���ֳ�Tϸ������������ſ�¡�ԡ�ަ��������S��zary�ۺ���Ϊ�����Ƥ��Tϸ���ܰ�����Tϸ������������ŵļ����Ƥ��Tϸ���ܰ����ķ��������о������ࡢ��ϡ��ж�Ԥ��������Ҫ�����á� | |||||||||||||||||||||||||||||||||||||||||||||||
�ؼ����� �ܰ���,Tϸ��,Ƥ�� �������� ����,��ԭ,Tϸ�� | |||||||||||||||||||||||||||||||||||||||||||||||
T Cell Receptor Gene Rearrangement in Cutaneous T-cell Lymphomas | |||||||||||||||||||||||||||||||||||||||||||||||
Shandong Provincial Institute of Dermatovenerology, Jinan 250022, China | |||||||||||||||||||||||||||||||||||||||||||||||
Shandong Provincial Institute of Dermatovenerology, Jinan 250022, China | |||||||||||||||||||||||||||||||||||||||||||||||
Abstract:
T cell receptor (TCR)gene rearrangement is an important event in T cell ontogeny that enables T cells to specifically recognise antigens, and any dysregulation in this process may result in diseases. Cuntaneous T-cell lymphoma(CTCL) is caused by malignant proliferation of individual lymphocyte, and its lesional tissue shows clonality of TCR gene rearrangement. Mycosis fungoides and Sezary syndrome are the most frequent clinical types of CTCL. The detection of TCR gene rearrangement has an important role in the study of the pathogenesis, classification, diagnosis and monitoring of prognosis of CTCL. | |||||||||||||||||||||||||||||||||||||||||||||||
Keywords: Lymphoma, T cell, cutaneous Gene rearrangement Receptor, T-cell | |||||||||||||||||||||||||||||||||||||||||||||||
�ո����� 2006-01-26 ������ ����淢������ | |||||||||||||||||||||||||||||||||||||||||||||||
DOI: | |||||||||||||||||||||||||||||||||||||||||||||||
������Ŀ: | |||||||||||||||||||||||||||||||||||||||||||||||
ͨѶ����: | |||||||||||||||||||||||||||||||||||||||||||||||
�����: | |||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||
�ο����ף� | |||||||||||||||||||||||||||||||||||||||||||||||
[1] Hughes J,Weston S,Bennetts B,et al.The application of a PCR technique for the detection of immunoglobulin heavy chain gene rearrangements in fresh or paraffin-embedded skin tissue.Pathology,2001,33:222-225. [2] Sandberg Y,van Gastel-Mol EJ,Verhaaf B,et al.BIOMED-2 multiplex immunoglobulin/T-cell receptor polymerase chain reaction protocols can reliably replace Southern blot analysis in routine clonality diagnostics.J Mol Diagn,2005,7:495-503. [3] Assaf C,Hummel M,Dippel E,et al.High detection rate of T-cell receptor beta chain rearrangements in T-cell lymphoproliferations by family specific polymerase chain reaction in combination with the GeneScan technique and DNA sequencing.Blood,2000,96:640-646. [4] Assaf C,Hummel M,Steinhoff M,et al.Early TCR-beta and TCR-gamma PCR detection of T-cell clonality indicates minimal tumor disease in lymph nodes of cutaneous T-cell lymphoma:diag nostic and prognostic implications.Blood,2005,105:503-510. [5] Wood GS.T-cell receptor and immunoglobulin gene rearrangements in diagnosing skin disease.Arch Dermatol,2001,137:1503-1506. [6] Veelken H,Wood GS,Sklar J.Molecular staging of cutaneous T-cell lymphoma:evidence for systemic involvement in early disease.J Invest Dermatol,1995,104:889-894. [7] Hodges E,Krishna MT,Pickard C,et al.Diagnostic role of tests for T cell receptor (TCR) genes.J Clin Pathol,2003,56:1-11. [8] Linnemann T,Gellrich S,Lukowsky A,et al.Polyclonal expansion of T cells with the TCR V beta type of the tumour cell in lesions of cutaneous T-cell lymphoma:evidence for possible superantigen involvement.Br J Dermatol,2004,150:1013-1017. [9] Sra KK,Babb-Tarbox M,Aboutalebi S,et al.Molecular diagnosis of cutaneous diseases.Arch Dermatol,2005,141:225-241. [10] Alessi E,Coggi A,Venegoni L,et al.The usefulness of clonality for the detection of cases clinically and/or histopathologically not recognized as cutaneous T-cell lymphoma.Br J Dermatol,2005,153:368-371. [11] Magro CM,Nuovo GJ,Crowson AN.The utility of the in situ detection ofT-cell receptor Beta rearrangements in cutaneous T-cell-dominant infiltrates.Diagn Mol Patrol,2003,12:133-141. [12] Fucich LF,Freeman SF,Boh EE,et al.Atypical cutaneous lymphocytic infiltrate and a role for quantitative immunohistochemistry and gene rearrangement studies.Int J Dermatol,1999,38:749-756. [13] Stevens SR,Ke MS,Birol A,et al.A simple clinical scoring system to improve the sensitivity and standardization of the diagnosis of mycosis fungoides type cutaneous T-cell lymphoma:logistic regression of clinical and laboratory data.Br J Dermatol,2003,149:513 -522. [14] Wood GS,Crooks CF,Uluer AZ.Lymphomatoid papulosis and associated cutaneous lymphoproliferative disorders exhibit a common clonal origin.J Invest Dermatol,1995,105:51-55. [15] Vega F,Luthra R,Medeiros LJ,et al.Clonal heterogeneity in mycosis fungoides and its relationship to clinical course.Blood,2002,100:3369-3373. [16] Fraser-Andrews EA,Russell-Jones R,Woolford A J,et al.Diagnostic and prognostic importance of T-cell receptor gene analysis in patients with Sezary syndrome.Cancer,2001,92:1745-1752. [17] Juarez T,Isenhath SN,Polissar NL,et al.Analysis ofT-cell receptor gene rearrangement for predicting clinical outcome in patients with cutaneous T-cell lymphoma:a comparison of Southern blot and polymerase chain reaction methods.Arch Dermatol,2005,141:1107-1113. |
|||||||||||||||||||||||||||||||||||||||||||||||
������������� | |||||||||||||||||||||||||||||||||||||||||||||||
1����Ө,֣��.Ƥ��Tϸ���ܰ����ķ��ࡢԤ������[J]. ����Ƥ���Բ�ѧ��־, 2007,33(4): 208- | |||||||||||||||||||||||||||||||||||||||||||||||
2�������� � ������ ����.Ƥ��CD8+�ױ�Ƥ��Tϸ���ܰ���һ��[J]. ����Ƥ���Բ�ѧ��־, 2009,35(5): 283-284 | |||||||||||||||||||||||||||||||||||||||||||||||
3����Ծƽ ������.��ʽϸ������ަ����ѿ��S��zary�ۺ����е�Ӧ��[J]. ����Ƥ���Բ�ѧ��־, 2010,36(5): 252-254 | |||||||||||||||||||||||||||||||||||||||||||||||
4����Ө, ֣��.Ƥ��Tϸ���ܰ����ķ��ࡢԤ������[J]. ����Ƥ���Բ�ѧ��־, 2007,33(4): 208-210 | |||||||||||||||||||||||||||||||||||||||||||||||
�������� (��ע��:��վʵ�������Ը�, �벻Ҫ������ѧ���ص�����!�������ݲ�����վ�۵�.) | |||||||||||||||||||||||||||||||||||||||||||||||
Copyright 2008 by ����Ƥ���Բ�ѧ��־ |